Westside Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.8K | Buy |
81
+31
| +62% | +$16.4K | 0.01% | 481 |
|
|
2025
Q1 | $31.7K | Hold |
50
| – | – | 0.01% | 476 |
|
|
2024
Q4 | $35.6K | Hold |
50
| – | – | 0.01% | 462 |
|
|
2024
Q3 | $52.6K | Hold |
50
| – | – | 0.01% | 397 |
|
|
2024
Q2 | $52.6K | Hold |
50
| – | – | 0.01% | 382 |
|
|
2024
Q1 | $48.1K | Hold |
50
| – | – | 0.01% | 385 |
|
|
2023
Q4 | $43.9K | Hold |
50
| – | – | 0.01% | 379 |
|
|
2023
Q3 | $41.1K | Hold |
50
| – | – | 0.01% | 373 |
|
|
2023
Q2 | $35.9K | Hold |
50
| – | – | 0.01% | 398 |
|
|
2023
Q1 | $41.1K | Sell |
50
-50
| -50% | -$41.1K | 0.01% | 381 |
|
|
2022
Q4 | $72 | Hold |
100
| – | – | ﹤0.01% | 388 |
|
|
2022
Q3 | $68 | Hold |
100
| – | – | ﹤0.01% | 388 |
|
|
2022
Q2 | $59 | Hold |
100
| – | – | ﹤0.01% | 395 |
|
|
2022
Q1 | $69 | Hold |
100
| – | – | ﹤0.01% | 393 |
|
|
2021
Q4 | $63 | Hold |
100
| – | – | ﹤0.01% | 385 |
|
|
2021
Q3 | $60 | Hold |
100
| – | – | ﹤0.01% | 379 |
|
|
2021
Q2 | $55 | Hold |
100
| – | – | ﹤0.01% | 372 |
|
|
2021
Q1 | $47 | Buy |
+100
| New | +$47 | ﹤0.01% | 379 |
|